01664oam 2200421 450 991070749280332120161123101558.0(CKB)5470000002464596(OCoLC)956436504(OCoLC)995470000002464596(EXLCZ)99547000000246459620160810d2010 ua 0engurmn|||||||||rdacontentrdamediardacarrierChallenges to FDA's ability to monitor and inspect foreign clinical trials /Department of Health and Human Services, Office of Inspector General[Washington, D.C.] :Department of Health and Human Services, Office of Inspector General,2010.1 online resource (iv, 43 pages) illustrations, color mapTitle from title screen (viewed Aug 9, 2016)."June 2010.""OEI-01-08-00510."Includes bibliographical references.Challenges to Food and Drug Administration's ability to monitor and inspect foreign clinical trialsClinical trialsGovernment policyUnited StatesBiologicalsTestingGovernment policyUnited StatesDrugsTestingGovernment policyUnited StatesClinical trialsGovernment policyBiologicalsTestingGovernment policyDrugsTestingGovernment policyGPOGPOGPOBOOK9910707492803321Challenges to FDA's ability to monitor and inspect foreign clinical trials3299502UNINA